Vasomotor Symptoms Market to Witness Upsurge in Growth During the Forecast Period (2022-32), Examine DelveInsight

DelveInsight's "Vasomotor Symptoms Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Vasomotor Symptoms Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Vasomotor Symptoms market report covers emerging drugs, treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Vasomotor Symptoms: An Overview
Vasomotor Symptoms (VMS) are episodes of profuse heat accompanied by sweating and flushing, which are experienced majorly around the head, neck, chest, and upper back. Vasomotor symptoms are often accompanied by hot flashes and night sweats and are often considered as the cardinal symptoms of menopause. The VMS may also include heart palpitations and changes in blood pressure.

VMS is a form of temperature dysfunction that occurs due to changes in gonadal hormones. Normally, core body temperature (CBT) remains within a specific range, oscillating with daily circadian rhythms. Physiological processes that conserve and dissipate heat are responsible for maintaining CBT, and tight regulation is important for maintaining optimal internal organ function.

According to the North American Menopause Society, up to 75% of females in the United States experience hot flashes around menopause. Hot flashes usually occur over a period lasting from 6 months to 2 years, but a person can experience them for up to 10 years. In the US, menopause usually begins between the ages of 45 and 58 years, and the average age for menopause is 52.

Vasomotor Symptoms Market Key Facts
• As per the DelveInsight estimates, in the year 2021, the total prevalent cases of Vasomotor Symptoms (VMS) were 136.02 million cases in the 7MM, which is expected to grow by 2032.
• The Vasomotor Symptoms (VMS) market is expected to grow significantly owing to increasing awareness, rising emerging therapies, novel mechanisms of action, and growing initiatives for R&D.
• With continuous efforts in research and development, various companies are developing therapies for Vasomotor symptoms (Hot flashes/Night sweats). Some of the key companies in the Vasomotor Symptoms Market include Mithra Pharmaceuticals, Bayer/Nerre Therapeutics Ltd., Astellas Pharma, MenoGeniX, Mitsubishi Tanabe Pharma, QUE Oncology, and several others.

Vasomotor Symptoms Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Vasomotor Symptoms market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Vasomotor Symptoms market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How Vasomotor Symptoms Market will Grow by 2032:
https://www.delveinsight.com/report-store/vasomotor-symptoms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Vasomotor Symptoms Epidemiology
The epidemiology section covers detailed insights into the historical and current Vasomotor Symptoms patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Vasomotor Symptoms Epidemiology Segmentation
• Total Prevalent Cases
• Total Treated Cases
• Total Severity-specific Cases
• Total Age-specific Cases

Get Key Insights Into the Evolving Vasomotor Symptoms Epidemiology Trends:
https://www.delveinsight.com/sample-request/vasomotor-symptoms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Vasomotor Symptoms Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vasomotor Symptoms market or expected to get launched in the market during the study period. The analysis covers Vasomotor Symptoms market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Vasomotor Symptoms Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/vasomotor-symptoms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Vasomotor Symptoms Therapeutics Assessment
Various treatment methods have been used to relieve hot flashes, including lifestyle modification, non-prescription remedies, and prescription therapies. As per DelveInsight's estimate, several ongoing clinical trial activities have been registered in the Vasomotor Symptoms Therapeutics segment.

Some of the key companies in the Vasomotor symptoms (Hot flashes/Night sweats) market include:
• Nerre Therapeutics
• Fervent Pharmaceuticals
• Sojournix
• TherapeuticsMD
• Mithra Pharmaceuticals
• KaNDy Therapeutics
• Fervent Pharmaceuticals
• Mitsubishi Tanabe Pharma
• Bayer/Nerre Therapeutics Ltd
• Astellas Pharma
• MenoGeniX
• Mitsubishi Tanabe Pharma
• QUE Oncology
And many others.

Vasomotor Symptoms (Hot Flashes/Night Sweats) Therapies covered in the report include:
• E4, Estetrol
• Elinzanetant (BAY-3427080, NT 814)
• Fezolinetant (ESN-364)
• MNGX-100(Filgrastim, G-CSF)
• NT-814
• FP-101
• Elismetrep (MT-8554)
• Q-122 (MSX-122)
And many others.

Learn More About the Emerging Therapies & Key Companies in the Vasomotor Symptoms Therapeutics Market:
https://www.delveinsight.com/sample-request/vasomotor-symptoms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Vasomotor Symptoms Competitive Intelligence Analysis
4. Vasomotor Symptoms Market Overview at a Glance
5. Vasomotor Symptoms Disease Background and Overview
6. Vasomotor Symptoms Patient Journey
7. Vasomotor Symptoms Epidemiology and Patient Population
8. Vasomotor Symptoms Treatment Algorithm, Current Treatment, and Medical Practices
9. Vasomotor Symptoms Unmet Needs
10. Key Endpoints of Vasomotor Symptoms Treatment
11. Vasomotor Symptoms Marketed Products
12. Vasomotor Symptoms Emerging Therapies
13. Vasomotor Symptoms Seven Major Market Analysis
14. Attribute Analysis
15. Vasomotor Symptoms Market Outlook (7 major markets)
16. Vasomotor Symptoms Access and Reimbursement Overview
17. KOL Views on the Vasomotor Symptoms Market.
18. Vasomotor Symptoms Market Drivers
19. Vasomotor Symptoms Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/vasomotor-symptoms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/vasomotor-symptoms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.